Jörg Striessnig, Ph.D. - Publications

Affiliations: 
University of Innsbruck, Innsbruck, Tirol, Austria 
Area:
Calcium Channels

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Aldrich RW, Attali B, Baggetta AM, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels. British Journal of Pharmacology. 178: S157-S245. PMID 34529831 DOI: 10.1111/bph.15539  0.427
2019 Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, ... ... Striessnig J, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. British Journal of Pharmacology. 176: S1-S20. PMID 31710719 DOI: 10.1111/Bph.14747  0.304
2019 Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology. 176: S142-S228. PMID 31710715 DOI: 10.1111/Bph.14749  0.318
2019 Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. Voltage-gated calcium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f80/2019.4  0.514
2019 Mesirca P, Mamaeva D, Bidaud I, Davaze R, Difrancesco M, Mitutsova V, Torrente A, Arsic N, Nargeot J, Striessnig J, Lee A, Lamb N, Mangoni M, Fernandez A. Bradycardic mice undergo effective heart rate improvement after specific homing to the sino-atrial node and differentiation of adult muscle derived stem cells Nature Communications. DOI: 10.1101/393512  0.443
2017 Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, ... Striessnig J, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview. British Journal of Pharmacology. 174: S1-S16. PMID 29055037 DOI: 10.1111/Bph.13882  0.338
2017 Alexander SP, Striessnig J, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels. British Journal of Pharmacology. 174: S160-S194. PMID 29055033 DOI: 10.1111/Bph.13884  0.348
2017 Monteleone S, Lieb A, Pinggera A, Negro G, Fuchs JE, Hofer F, Striessnig J, Tuluc P, Liedl KR. Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. Biophysical Journal. 113: 1485-1495. PMID 28978442 DOI: 10.1016/J.Bpj.2017.08.010  0.358
2017 Martínez-Rivera A, Hao J, Tropea TF, Giordano TP, Kosovsky M, Rice RC, Lee A, Huganir RL, Striessnig J, Addy NA, Han S, Rajadhyaksha AM. Enhancing VTA Cav1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Molecular Psychiatry. PMID 28194001 DOI: 10.1038/mp.2017.9  0.429
2016 Stanika R, Campiglio M, Pinggera A, Lee A, Striessnig J, Flucher BE, Obermair GJ. Splice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology. Scientific Reports. 6: 34528. PMID 27708393 DOI: 10.1038/Srep34528  0.513
2015 Marschallinger J, Sah A, Schmuckermair C, Unger M, Rotheneichner P, Kharitonova M, Waclawiczek A, Gerner P, Jaksch-Bogensperger H, Berger S, Striessnig J, Singewald N, Couillard-Despres S, Aigner L. The L-type calcium channel Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions. Cell Calcium. PMID 26459417 DOI: 10.1016/J.Ceca.2015.09.007  0.312
2015 Scharinger A, Eckrich S, Vandael DH, Schönig K, Koschak A, Hecker D, Kaur G, Lee A, Sah A, Bartsch D, Benedetti B, Lieb A, Schick B, Singewald N, Sinnegger-Brauns MJ, ... ... Striessnig J, et al. Cell-type-specific tuning of Cav1.3 Ca(2+)-channels by a C-terminal automodulatory domain. Frontiers in Cellular Neuroscience. 9: 309. PMID 26379493 DOI: 10.3389/Fncel.2015.00309  0.57
2015 Kaur G, Pinggera A, Ortner NJ, Lieb A, Sinnegger-Brauns MJ, Yarov-Yarovoy V, Obermair GJ, Flucher BE, Striessnig J. A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated CaV1.2 Calcium Channel Function. The Journal of Biological Chemistry. 290: 21086-100. PMID 26100638 DOI: 10.1074/Jbc.M115.645671  0.399
2015 Pinggera A, Lieb A, Benedetti B, Lampert M, Monteleone S, Liedl KR, Tuluc P, Striessnig J. CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biological Psychiatry. 77: 816-22. PMID 25620733 DOI: 10.1016/J.Biopsych.2014.11.020  0.335
2015 Yang G, Shi Y, Yu J, Li Y, Yu L, Welling A, Hofmann F, Striessnig J, Juntti-Berggren L, Berggren PO, Yang SN. CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. Cellular and Molecular Life Sciences : Cmls. 72: 1197-207. PMID 25292336 DOI: 10.1007/S00018-014-1737-6  0.373
2014 Ortner NJ, Bock G, Vandael DH, Mauersberger R, Draheim HJ, Gust R, Carbone E, Tuluc P, Striessnig J. Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. Nature Communications. 5: 3897. PMID 24941892 DOI: 10.1038/Ncomms4897  0.422
2014 Liu Y, Harding M, Pittman A, Dore J, Striessnig J, Rajadhyaksha A, Chen X. Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. Journal of Neurophysiology. 112: 1119-30. PMID 24848473 DOI: 10.1152/Jn.00757.2013  0.366
2014 Burtscher V, Knoflach D, Kugler C, Scharinger A, Glösmann M, Blatsios G, Janecke A, Striessnig J, Obermair GJ, Schicker KW, Koschak A. Is There a Contribution of Both Cav1.4 and Cav1.3 L-Type Calcium Channels to Retinal Synaptic Transmission? Biophysical Journal. 106: 332a. DOI: 10.1016/J.Bpj.2013.11.1906  0.368
2014 Eckrich S, Scharinger A, Muenkner S, Schönig K, Lee A, Bartsch D, Koschak A, Sinnegger-Brauns M, Hecker D, Schick B, Striessnig J, Engel J. C-Terminal Modulation of Cav1.3 L-Type Calcium Channels Modifies their Gating Properties in Cochlear Inner Hair Cells Biophysical Journal. 106: 329a. DOI: 10.1016/j.bpj.2013.11.1893  0.509
2013 Scharinger A, Schönig K, Bartsch D, Kaur G, Gebhart M, Sah A, Singewald N, Lee A, Koschak A, Sinnegger-Brauns MJ, Striessnig J. A Novel Animal Model to Study the In Vivo Role of a C-Terminal Regulatory Domain in Cav1.3 L-Type Calcium Channels Biophysical Journal. 104: 459a. DOI: 10.1016/j.bpj.2012.11.2539  0.463
2012 Christel CJ, Cardona N, Mesirca P, Herrmann S, Hofmann F, Striessnig J, Ludwig A, Mangoni ME, Lee A. Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node. The Journal of Physiology. 590: 6327-42. PMID 23045342 DOI: 10.1113/jphysiol.2012.239954  0.467
2011 Bock G, Gebhart M, Scharinger A, Jangsangthong W, Busquet P, Poggiani C, Sartori S, Mangoni ME, Sinnegger-Brauns MJ, Herzig S, Striessnig J, Koschak A. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. The Journal of Biological Chemistry. 286: 42736-48. PMID 21998310 DOI: 10.1074/Jbc.M111.269951  0.386
2011 Hirtz JJ, Boesen M, Braun N, Deitmer JW, Kramer F, Lohr C, Müller B, Nothwang HG, Striessnig J, Löhrke S, Friauf E. Cav1.3 calcium channels are required for normal development of the auditory brainstem. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8280-94. PMID 21632949 DOI: 10.1523/Jneurosci.5098-10.2011  0.379
2011 Mahapatra S, Marcantoni A, Vandael DH, Striessnig J, Carbone E. Are Ca(v)1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels (Austin, Tex.). 5: 219-24. PMID 21406973 DOI: 10.4161/Chan.5.3.15271  0.366
2011 Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism. Channels (Austin, Tex.). 5: 251-61. PMID 21406960 DOI: 10.4161/Chan.5.3.15266  0.391
2011 Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Pacemaker activity and ionic currents in mouse atrioventricular node cells. Channels (Austin, Tex.). 5: 241-50. PMID 21406959 DOI: 10.4161/Chan.5.3.15264  0.325
2011 Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nürnberg G, Ali A, Ahmad I, Sinnegger-Brauns MJ, Brandt N, Engel J, Mangoni ME, Farooq M, Khan HU, Nürnberg P, ... Striessnig J, et al. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nature Neuroscience. 14: 77-84. PMID 21131953 DOI: 10.1038/Nn.2694  0.397
2010 Müller CS, Haupt A, Bildl W, Schindler J, Knaus HG, Meissner M, Rammner B, Striessnig J, Flockerzi V, Fakler B, Schulte U. Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 107: 14950-7. PMID 20668236 DOI: 10.1073/Pnas.1005940107  0.412
2010 Gebhart M, Juhasz-Vedres G, Zuccotti A, Brandt N, Engel J, Trockenbacher A, Kaur G, Obermair GJ, Knipper M, Koschak A, Striessnig J. Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule. Molecular and Cellular Neurosciences. 44: 246-59. PMID 20363327 DOI: 10.1016/J.Mcn.2010.03.011  0.404
2010 Marcantoni A, Vandael DH, Mahapatra S, Carabelli V, Sinnegger-Brauns MJ, Striessnig J, Carbone E. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 491-504. PMID 20071512 DOI: 10.1523/Jneurosci.4961-09.2010  0.301
2010 Busquet P, Nguyen NK, Schmid E, Tanimoto N, Seeliger MW, Ben-Yosef T, Mizuno F, Akopian A, Striessnig J, Singewald N. CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 499-513. PMID 19664321 DOI: 10.1017/S1461145709990368  0.376
2009 Subramanyam P, Obermair GJ, Baumgartner S, Gebhart M, Striessnig J, Kaufmann WA, Geley S, Flucher BE. Activity and calcium regulate nuclear targeting of the calcium channel beta4b subunit in nerve and muscle cells. Channels (Austin, Tex.). 3: 343-55. PMID 19755859 DOI: 10.4161/Chan.3.5.9696  0.33
2008 Watschinger K, Horak SB, Schulze K, Obermair GJ, Wild C, Koschak A, Sinnegger-Brauns MJ, Tampé R, Striessnig J. Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels. Channels (Austin, Tex.). 2: 461-73. PMID 18797193 DOI: 10.4161/Chan.2.6.6793  0.428
2008 Mezghrani A, Monteil A, Watschinger K, Sinnegger-Brauns MJ, Barrère C, Bourinet E, Nargeot J, Striessnig J, Lory P. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4501-11. PMID 18434528 DOI: 10.1523/Jneurosci.2844-07.2008  0.418
2007 Navedo MF, Amberg GC, Westenbroek RE, Sinnegger-Brauns MJ, Catterall WA, Striessnig J, Santana LF. Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle. American Journal of Physiology. Heart and Circulatory Physiology. 293: H1359-70. PMID 17526649 DOI: 10.1152/Ajpheart.00450.2007  0.546
2007 Koschak A, Obermair GJ, Pivotto F, Sinnegger-Brauns MJ, Striessnig J, Pietrobon D. Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3855-63. PMID 17409250 DOI: 10.1523/Jneurosci.4028-06.2007  0.398
2007 Erazo-Fischer E, Striessnig J, Taschenberger H. The role of physiological afferent nerve activity during in vivo maturation of the calyx of Held synapse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1725-37. PMID 17301180 DOI: 10.1523/Jneurosci.4116-06.2007  0.322
2006 Mangoni ME, Couette B, Marger L, Bourinet E, Striessnig J, Nargeot J. Voltage-dependent calcium channels and cardiac pacemaker activity: from ionic currents to genes. Progress in Biophysics and Molecular Biology. 90: 38-63. PMID 15979127 DOI: 10.1016/J.Pbiomolbio.2005.05.003  0.393
2005 Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacological Reviews. 57: 411-25. PMID 16382099 DOI: 10.1124/Pr.57.4.5  0.474
2004 Kugler G, Grabner M, Platzer J, Striessnig J, Flucher BE. The monoclonal antibody mAB 1A binds to the excitation--contraction coupling domain in the II-III loop of the skeletal muscle calcium channel alpha(1S) subunit. Archives of Biochemistry and Biophysics. 427: 91-100. PMID 15178491 DOI: 10.1016/J.Abb.2004.04.007  0.361
2004 Matthes J, Yildirim L, Wietzorrek G, Reimer D, Striessnig J, Herzig S. Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 554-62. PMID 15146309 DOI: 10.1007/S00210-004-0940-7  0.315
2003 Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacological Reviews. 55: 579-81. PMID 14657414 DOI: 10.1124/Pr.55.4.8  0.481
2003 Wolf M, Eberhart A, Glossmann H, Striessnig J, Grigorieff N. Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. Journal of Molecular Biology. 332: 171-82. PMID 12946355 DOI: 10.1016/S0022-2836(03)00899-4  0.461
2003 Clark NC, Nagano N, Kuenzi FM, Jarolimek W, Huber I, Walter D, Wietzorrek G, Boyce S, Kullmann DM, Striessnig J, Seabrook GR. Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience. 120: 435-42. PMID 12890513 DOI: 10.1016/S0306-4522(03)00329-4  0.382
2003 Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proceedings of the National Academy of Sciences of the United States of America. 100: 5543-8. PMID 12700358 DOI: 10.1073/Pnas.0935295100  0.399
2003 Glueckert R, Wietzorrek G, Kammen-Jolly K, Scholtz A, Stephan K, Striessnig J, Schrott-Fischer A. Role of class D L-type Ca2+ channels for cochlear morphology. Hearing Research. 178: 95-105. PMID 12684182 DOI: 10.1016/S0378-5955(03)00054-6  0.349
2003 Koschak A, Reimer D, Walter D, Hoda J, Heinzle T, Grabner M, Striessnig J. Cav1.4α1 Subunits Can Form Slowly Inactivating Dihydropyridine-Sensitive L-Type Ca2+ Channels Lacking Ca2+-Dependent Inactivation The Journal of Neuroscience. 23: 6041-6049. DOI: 10.1523/Jneurosci.23-14-06041.2003  0.357
2002 Wappl E, Koschak A, Poteser M, Sinnegger MJ, Walter D, Eberhart A, Groschner K, Glossmann H, Kraus RL, Grabner M, Striessnig J. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. The Journal of Biological Chemistry. 277: 6960-6. PMID 11742003 DOI: 10.1074/Jbc.M110948200  0.601
2001 Barg S, Ma X, Eliasson L, Galvanovskis J, Göpel SO, Obermüller S, Platzer J, Renström E, Trus M, Atlas D, Striessnig J, Rorsman P. Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophysical Journal. 81: 3308-23. PMID 11720994 DOI: 10.1016/S0006-3495(01)75964-4  0.413
2001 Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. The Journal of Biological Chemistry. 276: 22100-6. PMID 11285265 DOI: 10.1074/Jbc.M101469200  0.594
2001 Wappl E, Mitterdorfer J, Glossmann H, Striessnig J. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits. The Journal of Biological Chemistry. 276: 12730-5. PMID 11278630 DOI: 10.1074/Jbc.M010164200  0.517
2001 Liu X, Rusch NJ, Striessnig J, Sarna SK. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology. 120: 480-9. PMID 11159888 DOI: 10.1053/gast.2001.21167  0.312
2000 Matthes J, Huber I, Haaf O, Antepohl W, Striessnig J, Herzig S. Pharmacodynamic interaction between mibefradil and other calcium channel blockers. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 578-83. PMID 10882031 DOI: 10.1007/S002100000239  0.38
2000 Eller P, Berjukov S, Wanner S, Huber I, Hering S, Knaus HG, Toth G, Kimball SD, Striessnig J. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. British Journal of Pharmacology. 130: 669-77. PMID 10821797 DOI: 10.1038/Sj.Bjp.0703352  0.439
2000 Huber I, Wappl E, Herzog A, Mitterdorfer J, Glossmann H, Langer T, Striessnig J. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. The Biochemical Journal. 347: 829-36. PMID 10769189 DOI: 10.1042/Bj3470829  0.517
2000 Kraus RL, Sinnegger MJ, Koschak A, Glossmann H, Stenirri S, Carrera P, Striessnig J. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. The Journal of Biological Chemistry. 275: 9239-43. PMID 10734061 DOI: 10.1074/Jbc.275.13.9239  0.517
1999 Leitner B, Lovisetti-Scamihorn P, Heilmann J, Striessnig J, Blakely RD, Eiden LE, Winkler H. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve. Journal of Neurochemistry. 72: 1110-6. PMID 10037482 DOI: 10.1046/J.1471-4159.1999.0721110.X  0.327
1998 Kraus RL, Hering S, Grabner M, Ostler D, Striessnig J. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels. The Journal of Biological Chemistry. 273: 27205-12. PMID 9765241 DOI: 10.1074/Jbc.273.42.27205  0.411
1998 Mitterdorfer J, Grabner M, Kraus RL, Hering S, Prinz H, Glossmann H, Striessnig J. Molecular basis of drug interaction with L-type Ca2+ channels. Journal of Bioenergetics and Biomembranes. 30: 319-34. PMID 9758329 DOI: 10.1023/A:1021933504909  0.614
1998 Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends in Pharmacological Sciences. 19: 108-15. PMID 9584627 DOI: 10.1016/S0165-6147(98)01171-7  0.626
1998 Kraus RL, Sinnegger MJ, Glossmann H, Hering S, Striessnig J. Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. The Journal of Biological Chemistry. 273: 5586-90. PMID 9488686 DOI: 10.1074/Jbc.273.10.5586  0.591
1997 Hering S, Aczél S, Kraus RL, Berjukow S, Striessnig J, Timin EN. Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation. Proceedings of the National Academy of Sciences of the United States of America. 94: 13323-8. PMID 9371844 DOI: 10.1073/Pnas.94.24.13323  0.424
1997 Sinnegger MJ, Wang Z, Grabner M, Hering S, Striessnig J, Glossmann H, Mitterdorfer J. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. The Journal of Biological Chemistry. 272: 27686-93. PMID 9346909 DOI: 10.1074/Jbc.272.44.27686  0.61
1997 Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J. Beta subunit heterogeneity in neuronal L-type Ca2+ channels. The Journal of Biological Chemistry. 272: 13877-82. PMID 9153247 DOI: 10.1074/Jbc.272.21.13877  0.347
1997 Safayhi H, Haase H, Kramer U, Bihlmayer A, Roenfeldt M, Ammon HP, Froschmayr M, Cassidy TN, Morano I, Ahlijanian MK, Striessnig J. L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Molecular Endocrinology (Baltimore, Md.). 11: 619-29. PMID 9139805 DOI: 10.1210/Mend.11.5.9922  0.685
1997 Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends in Pharmacological Sciences. 18: 67-70. PMID 9133773 DOI: 10.1016/S0165-6147(96)01037-1  0.517
1997 Brauns T, Prinz H, Kimball SD, Haugland RP, Striessnig J, Glossmann H. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other. Biochemistry. 36: 3625-31. PMID 9132014 DOI: 10.1021/Bi9613584  0.517
1997 Hinterdorfer P, Gruber HJ, Striessnig J, Glossmann H, Schindler H. Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry. 36: 4497-504. PMID 9109657 DOI: 10.1021/Bi962009C  0.517
1996 Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grabner M, Glossmann H. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. The Journal of Biological Chemistry. 271: 30330-5. PMID 8939992 DOI: 10.1074/Jbc.271.48.30330  0.563
1996 Berjukov S, Aczel S, Beyer B, Kimball SD, Dichtl M, Hering S, Striessnig J. Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels. British Journal of Pharmacology. 119: 1197-202. PMID 8937723 DOI: 10.1111/J.1476-5381.1996.Tb16022.X  0.42
1996 Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H, Striessnig J. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35: 14659-64. PMID 8931565 DOI: 10.1021/Bi961657T  0.599
1996 Hering S, Aczél S, Grabner M, Döring F, Berjukow S, Mitterdorfer J, Sinnegger MJ, Striessnig J, Degtiar VE, Wang Z, Glossmann H. Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. The Journal of Biological Chemistry. 271: 24471-5. PMID 8798706 DOI: 10.1074/Jbc.271.40.24471  0.601
1996 Mitterdorfer J, Froschmayr M, Grabner M, Moebius FF, Glossmann H, Striessnig J. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry. 35: 9400-6. PMID 8755718 DOI: 10.1021/Bi960683O  0.586
1996 Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proceedings of the National Academy of Sciences of the United States of America. 93: 8072-7. PMID 8755605 DOI: 10.1073/Pnas.93.15.8072  0.517
1996 Kraus R, Reichl B, Kimball SD, Grabner M, Murphy BJ, Catterall WA, Striessnig J. Identification of benz(othi)azepine-binding regions within L-type calcium channel alpha1 subunits. The Journal of Biological Chemistry. 271: 20113-8. PMID 8702733 DOI: 10.1074/jbc.271.33.20113  0.515
1996 Döring F, Degtiar VE, Grabner M, Striessnig J, Hering S, Glossman H. Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. The Journal of Biological Chemistry. 271: 11745-9. PMID 8662622 DOI: 10.1074/Jbc.271.20.11745  0.383
1996 Boer R, Dichtl M, Borchers C, Ulrich WR, Marecek JF, Prestwich GD, Glossmann H, Striessnig J. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry. 35: 1387-96. PMID 8634268 DOI: 10.1021/Bi951912U  0.517
1996 Grabner M, Wang Z, Hering S, Striessnig J, Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron. 16: 207-18. PMID 8562085 DOI: 10.1016/S0896-6273(00)80037-9  0.617
1995 Brauns T, Cai ZW, Kimball SD, Kang KC, Haugland RP, Berger W, Berjukov S, Hering S, Glossmann H, Striessnig J. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry. 34: 3461-9. PMID 7880840  0.545
1995 Hanner M, Moebius FF, Weber F, Grabner M, Striessnig J, Glossmann H. Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. The Journal of Biological Chemistry. 270: 7551-7. PMID 7706302 DOI: 10.1074/Jbc.270.13.7551  0.547
1995 Mitterdorfer J, Sinnegger MJ, Grabner M, Striessnig J, Glossmann H. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry. 34: 9350-5. PMID 7626604 DOI: 10.1021/Bi00029A010  0.555
1994 Grabner M, Bachmann A, Rosenthal F, Striessnig J, Schultz C, Tautz D, Glossmann H. Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. Febs Letters. 339: 189-94. PMID 8313972 DOI: 10.1016/0014-5793(94)80413-3  0.587
1994 Moebius FF, Hanner M, Knaus HG, Weber F, Striessnig J, Glossmann H. Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. The Journal of Biological Chemistry. 269: 29314-20. PMID 7961902  0.461
1994 Mitterdorfer J, Froschmayr M, Grabner M, Striessnig J, Glossmann H. Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. Febs Letters. 352: 141-5. PMID 7925963 DOI: 10.1016/0014-5793(94)00938-4  0.599
1994 Berger W, Prinz H, Striessnig J, Kang HC, Haugland R, Glossmann H. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer. Biochemistry. 33: 11875-83. PMID 7918406 DOI: 10.1021/Bi00205A025  0.526
1993 Moebius FF, Burrows GG, Striessnig J, Glossmann H. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Molecular Pharmacology. 43: 139-48. PMID 8429820  0.461
1993 Lakitsch M, Knaus HG, Topar G, Romanin C, Boer R, Flockerzi D, Striessnig J, Schindler H, Hoeltje HD, Glossmann H. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Molecular Pharmacology. 43: 293-301. PMID 8381514  0.461
1993 Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, Glossmann H. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Molecular Pharmacology. 44: 966-71. PMID 8246920  0.461
1993 Eismann E, Bönigk W, Kaupp B, Macdonald RL, Angelotti TP, Paulmichl M, Gschwentner M, Wöll E, Schmarda A, Ritter M, Kanin G, Ellemunter H, Waitz W, Deetjen P, Carroll TP, ... ... Striessnig J, et al. Subject Index, Vol. 3, 1993 Cellular Physiology and Biochemistry. 3: 401-402. DOI: 10.1159/000154702  0.486
1993 Striessnig J, Berger W, Glossmann H. Molecular properties of voltage-dependent ca2+ channels in excitable tissues Cellular Physiology and Biochemistry. 3: 295-317. DOI: 10.1159/000154695  0.517
1993 Eismann E, Bönigk W, Kaupp B, Macdonald RL, Angelotti TP, Paulmichl M, Gschwentner M, Wöll E, Schmarda A, Ritter M, Kanin G, Ellemunter H, Waitz W, Deetjen P, Carroll TP, ... ... Striessnig J, et al. Contents, Vol. 3, 1993 Cellular Physiology and Biochemistry. 3. DOI: 10.1159/000154687  0.484
1992 Florio V, Striessnig J, Catterall WA. Purification and reconstitution of skeletal muscle calcium channels. Methods in Enzymology. 207: 529-46. PMID 1382201 DOI: 10.1016/0076-6879(92)07037-O  0.552
1992 Catterall WA, Striessnig J. Receptor sites for Ca2+ channel antagonists. Trends in Pharmacological Sciences. 13: 256-62. PMID 1321525 DOI: 10.1016/0165-6147(92)90079-L  0.562
1992 Knaus HG, Striessnig J, Hering S, Marrer S, Schwenner E, Höltje HD, Glossmann H. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Molecular Pharmacology. 41: 298-307. PMID 1311409  0.461
1992 Striessnig J, Glossmann H. L-type calcium channels and calcium channel ligands Pharmacochemistry Library. 18: 333-343. DOI: 10.1016/B978-0-444-88931-7.50024-4  0.517
1991 Glossmann H, Zech C, Striessnig J, Staudinger R, Hall L, Greenberg R, Armah BI. Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes. British Journal of Pharmacology. 102: 446-52. PMID 1849770 DOI: 10.1111/J.1476-5381.1991.Tb12193.X  0.517
1991 Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, Schwartz A, Glossmann H. Calcium channels from Cyprinus carpio skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 88: 727-31. PMID 1846962 DOI: 10.1073/Pnas.88.3.727  0.593
1991 Striessnig J, Murphy BJ, Catterall WA. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Proceedings of the National Academy of Sciences of the United States of America. 88: 10769-73. PMID 1660150 DOI: 10.1073/Pnas.88.23.10769  0.541
1991 Ahlijanian MK, Striessnig J, Catterall WA. Phosphorylation of an alpha 1-like subunit of an omega-conotoxin-sensitive brain calcium channel by cAMP-dependent protein kinase and protein kinase. The Journal of Biological Chemistry. 266: 20192-7. PMID 1657916  0.717
1991 Nakayama H, Taki M, Striessnig J, Glossmann H, Catterall WA, Kanaoka Y. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proceedings of the National Academy of Sciences of the United States of America. 88: 9203-7. PMID 1656465  0.64
1991 Haase H, Striessnig J, Holtzhauer M, Vetter R, Glossmann H. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart. European Journal of Pharmacology. 207: 51-9. PMID 1655494 DOI: 10.1016/S0922-4106(05)80037-9  0.517
1991 Striessnig J, Glossmann H. [14] - Purification of L-Type Calcium Channel Drug Receptors Methods in Neurosciences. 4: 210-229. DOI: 10.1016/B978-0-12-185257-3.50019-7  0.517
1990 Striessnig J, Glossmann H, Catterall WA. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America. 87: 9108-12. PMID 2174553 DOI: 10.1073/Pnas.87.23.9108  0.682
1990 Glossmann H, Striessnig J. Molecular properties of calcium channels. Reviews of Physiology, Biochemistry and Pharmacology. 114: 1-105. PMID 2155469 DOI: 10.1007/Bfb0031018  0.517
1990 Striessnig J, Scheffauer F, Mitterdorfer J, Schirmer M, Glossmann H. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. The Journal of Biological Chemistry. 265: 363-70. PMID 2152924  0.461
1989 Grassegger A, Striessnig J, Weiler M, Knaus HG, Glossmann H. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 752-9. PMID 2561307 DOI: 10.1007/Bf00169685  0.599
1989 Glossmann H, Striessnig J, Knaus HG, Müller J, Grassegger A, Höltje HD, Marrer S, Hymel L, Schindler HG. Structure of calcium channels. Annals of the New York Academy of Sciences. 560: 198-214. PMID 2545133 DOI: 10.1111/J.1749-6632.1989.Tb24098.X  0.517
1989 Greenberg RM, Striessnig J, Koza A, Devay P, Glossmann H, Hall LM. Native and detergent-solubilized membrane extracts from Drosophila heads contain binding sites for phenylalkylamine calcium channel blockers Insect Biochemistry. 19: 309-322. DOI: 10.1016/0020-1790(89)90077-2  0.553
1989 Hymel L, Schindler H, Inui M, Fleischer S, Striessnig J, Glossmann H. A molecular model of excitation - contraction coupling at the skeletal muscle triad junction via coassociated oligomeric calcium channels Annals of the New York Academy of Sciences. 560: 185-188.  0.461
1988 Glossmann H, Striessnig J. Calcium channels. Vitamins and Hormones. 44: 155-328. PMID 2853487  0.461
1988 Striessnig J, Knaus HG, Glossmann H. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel. The Biochemical Journal. 253: 39-47. PMID 2844171 DOI: 10.1042/Bj2530039  0.517
1988 Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 331-40. PMID 2839780 DOI: 10.1007/Bf00168847  0.582
1988 Hymel L, Striessnig J, Glossmann H, Schindler H. Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proceedings of the National Academy of Sciences of the United States of America. 85: 4290-4. PMID 2454467 DOI: 10.1073/Pnas.85.12.4290  0.517
1988 Glossmann H, Striessnig J, Hymel L, Schindler H. Purification and reconstitution of calcium channel drug-receptor sites. Annals of the New York Academy of Sciences. 522: 150-61. PMID 2454049 DOI: 10.1111/J.1749-6632.1988.Tb33351.X  0.517
1988 Striessnig J, Glossmann H. Characterization of the drug receptors of the purified skeletal muscle calcium channel. Progress in Clinical and Biological Research. 252: 35-40. PMID 2450374  0.461
1988 Glossmann H, Striessnig J, Knaus H, Müller J, Zernig G, Moshammer T, Grassegger A. Radiochemicals in the study of receptors International Journal of Radiation Applications and Instrumentation. Part a. Applied Radiation and Isotopes. 39: 505. DOI: 10.1016/0883-2889(88)90201-8  0.517
1988 Glossmann H, Striessnig J. Structure and pharmacology of voltage-dependent calcium channels Isi Atlas of Science: Pharmacology. 2: 202-210.  0.461
1987 Knaus HG, Striessnig J, Koza A, Glossmann H. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 336: 583-6. PMID 2830547 DOI: 10.1007/Bf00169318  0.517
1987 Glossmann H, Striessnig J, Hymel L, Schindler H. Purified L-type calcium channels: only one single polypeptide (alpha 1-subunit) carries the drug receptor domains and is regulated by protein kinases. Biomedica Biochimica Acta. 46: S351-6. PMID 2449181  0.461
1987 Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. The Journal of Biological Chemistry. 262: 14337-42. PMID 2443504  0.461
1987 Glossmann H, Striessnig J, Ferry DR, Goll A, Moosburger K, Schirmer M. Interaction between calcium channel ligands and calcium channels. Circulation Research. 61: I30-6. PMID 2443273  0.461
1987 Striessnig J, Knaus HG, Grabner M, Moosburger K, Seitz W, Lietz H, Glossmann H. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. Febs Letters. 212: 247-53. PMID 2434359 DOI: 10.1016/0014-5793(87)81354-6  0.601
1987 Glossmann H, Ferry DR, Striessnig J, Goll A, Moosburger K. Resolving the structure of the Ca2+ channel by photoaffinity labelling Trends in Pharmacological Sciences. 8: 95-100. DOI: 10.1016/0165-6147(87)90082-4  0.517
1986 Striessnig J, Moosburger K, Goll A, Ferry DR, Glossmann H. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. European Journal of Biochemistry / Febs. 161: 603-9. PMID 2431906 DOI: 10.1111/J.1432-1033.1986.Tb10484.X  0.517
1986 Striessnig J, Goll A, Moosburger K, Glossmann H. Purified calcium channels have three allosterically coupled drug receptors. Febs Letters. 197: 204-10. PMID 2419161 DOI: 10.1016/0014-5793(86)80327-1  0.517
1985 Striessnig J, Zernig G, Glossmann H. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. European Journal of Biochemistry / Febs. 150: 67-77. PMID 2990927 DOI: 10.1111/J.1432-1033.1985.Tb08989.X  0.517
1985 Striessnig J, Zernig G, Glossmann H. Ca2+ antagonist receptor sites on human red blood cell membranes. European Journal of Pharmacology. 108: 329-30. PMID 2985404 DOI: 10.1016/0014-2999(85)90460-1  0.517
1985 Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G. Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittel-Forschung. 35: 1917-35. PMID 2420337  0.461
1985 Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M. Calcium channels: basic properties as revealed by radioligand binding studies. Journal of Cardiovascular Pharmacology. 7: S20-30. PMID 2414589  0.554
1984 Goll A, Ferry DR, Striessnig J, Schober M, Glossmann H. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. Febs Letters. 176: 371-7. PMID 6092142 DOI: 10.1016/0014-5793(84)81199-0  0.585
Show low-probability matches.